tirzepatide weight loss studies once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide weight-loss study shows promising

If you are on a GLP-1 watch this

Discover expert strategies for prior authorization and cost-saving options.

The lightweight, non-greasy design adheres comfortably to the skin, making them suitable for use at home, work, travel, or during daily activities

Early detection of NAION symptoms and timely drug discontinuation may be critical in preventing permanent vision loss

At Restore Hyper Wellness Durham, NC, our personalized GLP-1 weight loss Plans provide clinical guidance customized to your goals and unique health data.

Clinical trials and pooled analyses have shown that the combination has a safety profile similar to each component alone, with a low incidence of hypoglycemia (unless combined with insulin or sulfonylureas)